CTN :40951159
31 Jul, 2025
8.00 Crore
Tender For rate contract of drugs and medicines - rate contract of medicines :-, lignocaine and adrenaline inj. 20mg + 0.01mg 30 ml vial, anti thymocyte globulin, growth harmone, imipenum + cilastatin 500, l-carnitine, nandrolone 25 mg, netilmicin 100 mg, netilimicin 200 mg, netilimicin 300 mg., netilmicin 10 mg, palonosetron 1.5ml, testosterone propionate 250 mg (enantate) / ml, tobramycin 20 mg, vitamin b1 + b6 + b12, voriconazole lypholised 200, amikacin injection 2 ml vial 500 mg, mupirocin skin ointment, plaster of paris i.p .in 25kg .bag in polythene lined hdpe moisture and insect proof bag), plaster of paris i.p .in 50kg. bag in polythene lined hdpe moisture and insect proof bag, protin powder 225 gm, formetrol + fluticosone 200/ 400 r/ c, 0.55% w/wortho - phthalaldehyde (1,2-benzene di carboxaldehyde) solution, usfda & usep aapproved, ndorsed by reputed manufacturers of medical, 1% available iodine with surfactant for skin preparationand cleaning, carbolicacid (phenol) 400 ml, low foam enzymatic detergent solutioncontaining fourenzymes : bacterialprotease, alpha-amylase, lipase, cellulase, sodium tetraborate decahydrate, us epa/ usfda approved 3.78 ltr bottle, surface, environmentandinstrument disinfectant (didecyl dimithyl ammonium chlorid + gluteral + glyoxal disinfectant)1lit., disodium hydrogen citrate, cyproheptadine syp, bcomplex syrup 100 ml, amoxycillin and potassium clavulanate tabs 500 mg + 125 mg, fexofenidine 120 mg, fexofenidine 180 mg, isoniazid 300 mg, amoxicillin and clavulanic acid injection 600 mg, mycophenolate mofetil500 mg, amoxicillin and potassium clavulanate injection 1.2 gm, tacrolimus 1 mg, ampicillin capsule 500 mg, acarbose 25 mg, capecitabine 500 mg, carvedilol 3.125 mg, chlothalidone 6.25 mg, chlothalidone 12.5 mg, bupivacaine hydrochloride in dextrose injection 5mg + 80 mg per ml, alfuzosin 10 mg, dutasteride 0.5 mg, lacosamide 100mg, tab. chlorthalidone 12.5mg, cefoperazone and sulbactum for injection 1 g + 0.5 g, cefotaxime injection 1 g, ceftazidime injection 1 g, ceftazidime injection 500 mg, ceftriaxone injection ip 1 g/ vial, ceftriaxone injection ip 500 mg/ vial, cefuroxime tablet 250 mg, ciprofloxacin injection 200 mg/ 100 ml, ofloxacin injection 200mg / 100 ml, co-trimoxazole oral suspension ip each 5 ml contains trimethoprim 40 mg and sulphamethoxazole 200 mg, doxycycline capsule 100 mg, tramadol capsule 50 mg, vancomycin injection 500 mg, aztreonam 1gm injection, tramadol injection 50 mg/ ml, metronidazole injection 500 mg/ 100 ml, metronidazole benzoate oral suspension 100 mg/ 5 ml, albendazole oral suspension 400 mg/ 10 ml, clotrimazole cream ip 2% w/ w, fluconazole tablet 150 mg, amphotericin b injection 50 mg, artisunate injection 60 mg (combo pack with 1 ml ampoule of 5% sodium bicarbonate injection and 5 ml ampoule of 0.9% sodium chloride injection), acyclovir tablet 200 mg, acyclovir tablet 800 mg, acyclovir suspension 400 mg/ 5ml, bleomycin injection 15 units, cyclophosphamide injection 200 mg, cyclophosphamide injection ip 500 mg, cytarabine injection 100 mg/ 5 ml, fluorouracil injection 250 mg/ 5 ml, methotrexate injection 50 mg/ 2 ml, tamoxifen tablet 10 mg, vinblastine injection 10 mg/ 10 ml, vincristine injection 1 mg/ ml, gemcitabine injection 200 mg, imatinib tablet 400 mg, methotrexate tablet ip 10 mg, class="text-red-selected">mitomycin c inje
ction 10 mg, di
clofena
c gel: di
clofena
c diethylamine , methyl sali
cylate , linseed oil and menthol 1.16%+10%+3%+ 5%, 20gm, inj. beva
cizumab 400 mg, inj. beva
cizumab 100 mg, di
clofena
c sodium inje
ction - for im and iv 25 mg/ ml, warfarin sod. tablet 5 mg, tranexami
c a
cid tablet 500 mg, dried fa
ctor viii fra
ction (iv use) 250 iu, ketamine inje
ction 50 mg/ ml, dried fa
ctor viii fra
ction (iv use) 500 iu, fa
ctor ix
con
centrate 600 iu, anti- inhibitor
coagulation
complex [human plasma protein with a fa
ctor viii inhibitor bypassing a
ctivity of 500 i.u. per vial 500 iu], deferiprone
capsule 500 mg, rh-erythropoetin inje
ction 2000 iu, rh-erythropoetin inje
ction 40